NPPA issues clarification on discontinues the sale of coronary stent in Indian Market

Feb 26, 2018 | by Avantis RegTech Legal Research Team

National Pharmaceutical Pricing Authority (NPPA) vide office memorandum dated February 21, 2018has decided not to disallow any application submitted forwithdrawal ofstents, from the market by the stent manufacturer/importers.

Anymanufacturerintending to discontinueproduction or import ofany Coronary Stentshallfurnish information to the NPPA, in respect ofdiscontinuation ofproduction and/orimportin Form-IV ofSchedule-II of the DPCO, 2013 atleast 6 months priorto the intended date of discontinuation as prescribed under paragraph 21(2) ofthe DPCO, 2013 andfollow the ceiling price in such manner andtillsuch a time prescribed bythe Government.

[F.No.20 (8)/2018/Div-III/NPPA/]



Related Updates

Alternate Text

Get updates on the go on RuleZbook Mobile App.